Forbes March 31, 2025
Alex Knapp

The Napster cofounder’s cancer fighting non-profit is investing hundreds of millions into research and the startups that spring from it.

Of all the cuts the Trump Administration has made, its attacks on medical research are some of the most baffling, threatening the ability for American scientists to keep developing new medicines to treat everything from cancer to Parkinson’s.

For billionaire Sean Parker, who told Forbes he’s been heavily involved in lobbying to boost federal spending on medical research, that means philanthropies and the private sector will have to step in to fill some of the gap.

“We’ve seen this incredible,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Investments, Pharma / Biotech, Trends
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions

Share This Article